$1,000 invested Gilead Sciences Inc. (2023)
NASDAQ · GILD · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-08-28
Today you would have
$1,907
+$907 (+90.67%)
GILDSPY (benchmark)
- Entry price
- $76.40
- Current price
- $145.68
- Shares
- 13.0882
- CAGR
- +19.34%
- Max Drawdown
- -26.59%
- vs SPY
- -20.07 pp
✦The story
A $1,000 position in Gilead Sciences opened in early 2023 was worth $1,907 by mid-2026, a gain of +90.7%. The biotech continued to rely on its HIV treatment franchise while expanding into oncology. Over the same period the S&P 500 gained +110.7%, outpacing the stock.
#Related scenariosfor comparison
Other years for GILD